Literature DB >> 20138662

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

Chunbai He1, Yiping Hu, Lichen Yin, Cui Tang, Chunhua Yin.   

Abstract

To elucidate the effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles (NPs), rhodamine B (RhB) labeled carboxymethyl chitosan grafted NPs (RhB-CMCNP) and chitosan hydrochloride grafted NPs (RhB-CHNP) were developed as the model negatively and positively charged polymeric NPs, respectively. These NPs owned well defined particle sizes (150-500 nm) and Zeta potentials (-40 mV - +35 mV). FITC labeled protamine sulfate (FITC-PS) loaded RhB-CMCNP and camptothecin (CPT) loaded RhB-CHNP with high encapsulation efficiency were prepared. The fluorescence stability in plasma and towards I(-) was investigated, and the result indicated it was sufficient for qualitative and quantitative analysis. NPs with high surface charge and large particle size were phagocytized more efficiently by murine macrophage. Slight particle size and surface charge differences and different cell lines had significant implications in the cellular uptake of NPs, and various mechanisms were involved in the uptake process. In vivo biodistribution suggested that NPs with slight negative charges and particle size of 150 nm were tended to accumulate in tumor more efficiently. These results could serve as a guideline in the rational design of drug nanocarriers with maximized therapeutic efficacy and predictable in vivo properties, in which the control of particle size and surface charge was of significance. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138662     DOI: 10.1016/j.biomaterials.2010.01.065

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  455 in total

1.  Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.

Authors:  José das Neves; Johan Michiels; Kevin K Ariën; Guido Vanham; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

2.  Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population.

Authors:  Jong Ah Kim; Christoffer Åberg; Anna Salvati; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2011-11-06       Impact factor: 39.213

Review 3.  Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.

Authors:  José M Morachis; Enas A Mahmoud; Adah Almutairi
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

Review 4.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

5.  Scattering based hyperspectral imaging of plasmonic nanoplate clusters towards biomedical applications.

Authors:  Aniruddha Ray; Raoul Kopelman; Bonghwan Chon; Kimberly Briggman; Jeeseong Hwang
Journal:  J Biophotonics       Date:  2015-09-16       Impact factor: 3.207

6.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 7.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

8.  Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.

Authors:  Noha Nafee; Dina M Gaber; Ahmed O Elzoghby; Maged W Helmy; Osama Y Abdallah
Journal:  Pharm Res       Date:  2020-04-14       Impact factor: 4.200

9.  The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors.

Authors:  Lei Miao; Jay M Newby; C Michael Lin; Lu Zhang; Feifei Xu; William Y Kim; M Gregory Forest; Samuel K Lai; Matthew I Milowsky; Sara E Wobker; Leaf Huang
Journal:  ACS Nano       Date:  2016-09-28       Impact factor: 15.881

10.  Perspectives on clinical translation of smart nanotherapeutics.

Authors:  Joyce Lee; Kit S Lam
Journal:  Ther Deliv       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.